Recruiting Hemophilia Studies in Hamilton
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Study B7841007 is an open-label extension study to assess the long-term safety, tolerability, and efficacy of prophylaxis treatment with marstacimab in participants who did not require "Early Terminat...
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Participants in this study have a genetic mutation, specifically in the coagulation (blood clotting) Factor 9 gene that causes severe or moderately severe hemophilia B. This study is researching an ex...
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
WP44714 is a Phase I/II, open-label, non-randomized, global, multicenter trial consisting of two parts: * Part 1 is a multiple-ascending dose (MAD) study in adult and adolescent male participants wit...
Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)
The purpose of this study is to assess the risk of bleeding due to failure of expected pharmacological action of CSL222 in adults with severe or moderately severe hemophilia B with detectable pretreat...
About Hemophilia Clinical Trials in Hamilton
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 4 hemophilia clinical trials recruiting participants in Hamilton, ONTARIO. These studies are seeking a combined 470 participants. Research is being sponsored by Pfizer, Regeneron Pharmaceuticals, Hoffmann-La Roche and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in Hamilton — FAQ
Are there hemophilia clinical trials in Hamilton?
Yes, there are 4 hemophilia clinical trials currently recruiting in Hamilton, ONTARIO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Hamilton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hamilton research site will contact you about next steps.
Are clinical trials in Hamilton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hamilton studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 4 active trials in Hamilton are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated March 2, 2026 from ClinicalTrials.gov